A Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Assess the Immune Response Following Administration of Zoster Vaccine to Subjects With Rheumatoid Arthritis Receiving Tofacitinib (CP-690,550) Or Placebo With Background Methotrexate Treatment
Phase of Trial: Phase II
Latest Information Update: 28 Aug 2017
At a glance
- Drugs Tofacitinib (Primary) ; Varicella zoster virus vaccine
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics
- Sponsors Pfizer
- 28 Aug 2017 Results published in the Arthritis and Rheumatology
- 17 Jun 2017 Results presented at the 18th Annual Congress of the European League Against Rheumatism.
- 03 Aug 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.